Recruiting
Phase 2

Inotuzumab Ozogamicin & Chemotherapy

Sponsor:

Alliance for Clinical Trials in Oncology

Code:

NCT05303792

Conditions

B Acute Lymphoblastic Leukemia

B Lymphoblastic Lymphoma

Eligibility Criteria

Sex: All

Age: 50+

Healthy Volunteers: Not accepted

Interventions

Cyclophosphamide

Vincristine

Dexamethasone

Inotuzumab Ozogamicin

Methotrexate

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information